ArticleJournal of hepatology2023

LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma.

Caitlin B Conboy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.